ClinicalTrials.gg
Status unknownNCT02689128Updated Feb 23, 2016

Postoperative Nausea and Vomiting: to Estimate the Incidence and Risk Factors in a Tertiary Teaching Hospital

An observational study in Postoperative Nausea and Vomiting, sponsored by University of Jordan. Status unknown at 1 site in Jordan. Per ClinicalTrials.gov, last updated 2016-02-23.

Sponsored by University of Jordan · Observational

The sponsor has not verified this record recently (last verified Feb 2016), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
6,000
Sex
All
01

Study summary

Postoperative nausea and vomiting (PONV) is a frequent complication of surgery and anesthesia.

The aim of this study is to estimate the incidence and the risk factors of PONV at Jordan University Hospital over one year period.

Read the detailed description

Postoperative nausea and vomiting (PONV) is a frequent complication of surgery and anesthesia, in the literature it reaches up to 70% of the surgical patients and it occurs after local and general anesthesia with surgery.

Locally in Jordan there was no proper clinical study to estimate PONV among surgical patients, the aim of this study is to estimate the incidence and the risk factors of PONV at Jordan University Hospital over one year period.

02

Conditions studied

  • Postoperative Nausea and Vomiting

Keywords

  • Anesthesia
  • postoperative
  • nausea
  • vomiting
03

In context

Postoperative Nausea and Vomiting

629 studies on the registry are indexed under Postoperative Nausea and Vomiting; 113 are open to participants now.

This study's planned enrollment of 6,000 is above the median of 197 across 88 observational studies indexed under Postoperative Nausea and Vomiting.

Browse Postoperative Nausea and Vomiting studies →

Lead sponsor

University of Jordan is the lead sponsor of 130 studies on the registry; 20 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients who undergoes anesthesia and surgery and suffer from postoperative nausea and vomiting for 24 hours

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients who undergoes anesthesia and surgery.
  • Patients who suffer from postoperative nausea and vomiting for 24 hours.

Exclusion criteria

Exclusion Criteria:

  • Patients who suffer from postoperative nausea and vomiting after 24 hours.
  • Patients who undergoes Day-case surgery.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
6,000 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Postoperative nausea and vomiting

    Time frame: 24 hours

07

Study locations

1 of 1 sites recruiting
  • University of Jordan
    Amman, 11942, Jordan
    • Amira T Masri, Professor · Contact · amasri@ju.edu.jo · 00962 6 5353444
    • Salameh S Obeidat, M.B.B.S · Sub investigator
    Recruiting
08

References and documents

Publications

  • Hambridge K. Assessing the risk of post-operative nausea and vomiting. Nurs Stand. 2013 Jan 2-8;27(18):35-43. doi: 10.7748/ns2013.01.27.18.35.c9486. PubMed 23431652 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Jan 2016, a primary completion of Dec 2016 and a completion of Mar 2017. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 18, 2016
First posted
Feb 23, 2016
Start
Jan 2016
Primary completionEst.
Dec 2016
CompletionEst.
Mar 2017
Last update
Feb 23, 2016
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 23, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02689128
Responsible party
Subhi M. Alghanem (Professor of Anesthesia and Intensive Care, University of Jordan) — Principal investigator
First posted
Feb 23, 2016
Start date
Jan 2016
Primary completion
Dec 2016 (estimated)
Completion
Mar 2017 (estimated)
Last update
Feb 23, 2016

Study contacts

Subhi M Alghanem, FFARCS
Contact
alghanem@ju.edu.jo
00962795640592
Subhi M Alghanem, FFARCS
study chair · University of Jordan

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Feb 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion